This compound is being actively studied in clinical trials for its potential therapeutic benefits in treating mental health conditions such as depression, anxiety, and addiction. Research suggests it may promote brain plasticity and support changes in thought patterns.
Explore Research Findings
Leading institutions, including Johns Hopkins Medicine, are conducting clinical trials on this compound. These studies show promising results when used in combination with psychotherapy for various conditions:
Therapy involving this compound has received "breakthrough therapy" designation from the FDA, demonstrating potential for rapid and sustained symptom improvement, often after one or two guided sessions.
Studies indicate that a single guided dose can significantly improve quality of life and reduce anxiety and depression, with effects lasting for months.
Clinical trials suggest effectiveness in treating alcohol use disorder and aiding smoking cessation when combined with psychotherapy.
Early research explores potential benefits for obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and severe cluster headaches, though additional studies are needed.
This compound acts primarily on serotonin receptors in the brain, resulting in several key effects:
Documented benefits are observed primarily in controlled clinical settings with trained therapists present to guide and support the process.
These may include temporary anxiety, increased blood pressure, nausea, or, in rare cases, psychological challenges, especially in individuals with certain predispositions.
While low-dose regimens are popular, scientific studies have generally found limited benefits beyond placebo effects.
Stay informed about ongoing developments in research on this therapeutic compound and mental health treatment.
Updated: December 2025